TRAFALGAR INTERNATIONAL, INC. (GCAN) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US3916572023
Price
0.75 USD
Market cap
149,156.85 USD
P/E (2025)
–
P/S (2025)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
44.71 %
Return on assets (ROA)
-40,688.59 %
TRAFALGAR INTERNATIONAL, INC. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Operating income | -156,276.00 USD | -183,005.00 USD |
| EBIT | -179,041.00 USD | -331,612.00 USD |
| Net income | -179,041.00 USD | -331,612.00 USD |
| Diluted EPS – continuing operations | 0.00 USD | 0.00 USD |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About TRAFALGAR INTERNATIONAL, INC.
Trafalgar International, Inc. focuses on acquiring, developing and growing businesses in the financial services, technology and intellectual property sectors. The company was formerly known as The Greater Cannabis Company, Inc. and changed its name to Trafalgar International, Inc. in July 2026. The company was founded in 2014 and is based in Miami, Florida.
More stocks
- ENCISION INC (ECIA)
- NITCHES INC (NICH)
- AMAZE HOLDINGS, INC. (AMZE)
- La Rosa Holdings Corp. (LRHC)
- ENvue Medical, Inc. (FEED)
- Nextel Medical Corp. (MAJI)
- Jubilant Flame International, Ltd (JFIL)
- CUMULUS MEDIA INC (CMLSQ)
- Glucotrack, Inc. (GCTK)
- NetBrands Corp. (NBND)
- Mobile Global Esports, Inc. (MGAM)
- Nature's Miracle Holding Inc. (NMHI)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.